Insulin resistance and central obesity determine hepatic steatosis and explain cardiovascular risk in steatotic liver disease

Insulin resistance and central obesity determine hepatic steatosis and explain cardiovascular risk in steatotic liver disease

BackgroundMetabolic dysfunction-associated steatotic liver disease (MASLD) has recently been proposed to replace non-alcoholic fatty liver disease and focus on patients with progressive disease due to the presence of metabolic dysfunction. However, it is unclear whether the new definition actually i...

Full description

Bibliographic Details
Main Authors: Georg Semmler, Lorenz Balcar, Sarah Wernly, Andreas Völkerer, Lorenz Semmler, Laurenz Hauptmann, Bernhard Wernly, Elmar Aigner, David Niederseer, Christian Datz
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Endocrinology
Subjects:
MASLD
NAFLD
steatotic liver disease
metabolic syndrome
insulin resistance
SCORE2
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1244405/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2023.1244405/full

Similar Items